Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nature

• Publication date

  2001-04-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/35074129PMID 11323676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Molecular abnormalities in lung cancer].

  2002cited by this paper
• Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

  2000cited by this paper
• Atypical adenomatous hyperplasia of the lung problems in operative management.

  2000cited by this paper
• Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma

  2000cited by this paper
• Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells

  2000cited by this paper
• TAP expression provides a general method for improving the recognition of malignant cells in vivo

  2000cited by this paper
• Modeling human lung cancer in mice: similarities and shortcomings

  1999cited by this paper
• Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma.

  1999cited by this paper
• Molecular abnormalities in lung cancer.

  1998cited by this paper
• K-ras is an essential gene in the mouse with partial functional overlap with N-ras.

  1997cited by this paper
• Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design.

  1997cited by this paper
• Inhibitors of prenyl transferases

  1997cited by this paper
• Allelic variation in the mouse Tap-1 and Tap-2 transporter genes.

  1997cited by this paper
• Differential distribution and increased levels of ras proteins during lung development.

  1997cited by this paper
• Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

  1997cited by this paper
• Laser Capture Microdissection: Molecular Analysis of Tissue

  1997cited by this paper
• Decreased tumor surveillance in perforin-deficient mice

  1996cited by this paper
• Tissue-specific targeting of cytokine unresponsiveness in transgenic mice.

  1995cited by this paper
• Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.

  1995cited by this paper
• Frequent and characteristic K‐ras activation in aberrant crypt foci of colon. Is there preference among K‐ras mutants for malignant progression?

  1995cited by this paper
• The Ras signal transduction pathway

  1994cited by this paper
• Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

  1994cited by this paper
• K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

  1994cited by this paper
• Tumor spectrum analysis in p53-mutant mice.

  1994cited by this paper
• Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic.

  1994cited by this paper
• Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

  1994cited by this paper
• Predisposition to neoplastic transformation caused by gene replacement of H-ras1.

  1993cited by this paper
• Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets.

  1992cited by this paper
• Aberrant crypts: putative preneoplastic foci in human colonic mucosa.

  1991cited by this paper
• Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells

  1991cited by this paper
• Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells

  1991cited by this paper
• Transgenic models of tumor development.

  1991cited by this paper
• A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

  1990cited by this paper
• Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7.

  1990cited by this paper
• Alveolar epithelial hyperplasia and adenocarcinoma of the lung.

  1990cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Somatic and germ-line reverse mutation rates of the retrovirus-induced dilute coat-color mutation of DBA mice.

  1988cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• The ras gene family and human carcinogenesis.

  1988cited by this paper
• The composition of the T cell receptor repertoire in nude mice.

  1987cited by this paper
• Prevalence of ras gene mutations in human colorectal cancers

  1987cited by this paper
• Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation.

  1986cited by this paper
• Spontaneous tumors in nude mice: effect of the viable yellow gene.

  1979cited by this paper
• Immunogenetics of cell surface antigens of mouse leukemia.

  1977cited by this paper
• Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice

  1974cited by this paper

• Evaluating the implications of K-Ras, KEAP1/NRF2-mediated signaling pathways and metabolic alterations in urethane-induced lung cancer

  2026cites this paper
• Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen Exposure.

  2026cites this paper
• Divergent CD45+ immune landscapes shape the lung tumor microenvironment.

  2026cites this paper
• Allosteric Binding-Mediated Suppression on Activity of G12D KRAS Recognized via Markov State Model and Communication Pathway.

  2026cites this paper
• Targeting PP2A in cancer: an underrated option

  2025cites this paper
• Hyaluronan network remodeling by ZEB1 and ITIH2 enhances the motility and invasiveness of cancer cells

  2025cites this paper
• KRAS mutant colon cancer-targeted induction of ferroptosis via photocatalytic activation of BiVO4-embedded silica nano with cascadic downregulation of GPX4/xCT axis

  2025cites this paper
• Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status

  2025cites this paper
• SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model and its catalytic activity is regulated by histone acetylation

  2025cites this paper
• Murine models of lung adenocarcinoma: Valuable tools for preclinical investigation.

  2025cites this paper
• A Novel Prognostic Model of Endometrial Cancer Based on Inflammation and Lipid Metabolism Genes

  2025cites this paper
• Computational prediction of human genetic variants in the mouse genome.

  2025cites this paper
• Human Pluripotent Stem Cell-Derived Alveolar Organoids for Gene-editing and Lung Adenocarcinomas Modeling

  2025cites this paper
• p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program

  2025cites this paper
• Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer

  2025cites this paper
• Reassessing the roles of oxidative DNA base lesion 8-oxoGua and repair enzyme OGG1 in tumorigenesis

  2025cites this paper
• A novel mouse model of diverse tumors derived from epithelial cells

  2025cites this paper
• Tumor cell-specific loss of GPX4 reprograms triacylglycerol metabolism to escape ferroptosis and impair antitumor immunity in NSCLC

  2025cites this paper
• Modeling tumor relapse using proliferation tracing and ablation transgenic mouse

  2025cites this paper
• SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model, and its catalytic activity is regulated by histone acetylation

  2025cites this paper
• Lung adenocarcinoma–derived IFN-γ promotes growth by modulating CD8+ T cell production of CCR5 chemokines

  2025cites this paper
• Long noncoding RNA-dependent control of Myc transcriptional bursting

  2025cites this paper
• Activation of Pvt1b isoform contributes to local Pvt1 abundance to repress Myc during stress

  2025cites this paper
• Spatially defined multicellular functional units in colorectal cancer revealed from single cell and spatial transcriptomics

  2025cites this paper
• Spatially defined multicellular functional units in colorectal cancer revealed from single cell and spatial transcriptomics

  2025cites this paper
• Computational modeling of human genetic variants in mice

  2025cites this paper
• Orthotopically Implanted Murine Lung Adenocarcinoma Cell Lines for Preclinical Investigations

  2025cites this paper
• Cell cycle duration determines oncogenic transformation capacity

  2025cites this paper
• B-Cell Co-culture in the Tumor Microenvironment of Solid Tumors Using Pancreatic Cancer as a Tumor Model.

  2025cites this paper
• SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD

  2025cites this paper
• Baseline expression of c-Myc defines the tissue specificity of oncogenic K-Ras

  2025cites this paper
• FTO‐mediated m6A demethylation regulates IGFBP3 expression and AKT activation through IMP3‐dependent P‐body re‐localisation in lung cancer

  2025cites this paper
• Poor therapeutic outcomes in KRAS-mutant non-small cell lung cancer due to chemoresistance conferred by SLC7A11

  2024cites this paper
• Drugging the undruggable: Advances in targeting KRAS signaling in solid tumors.

  2024cites this paper
• NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer

  2024cites this paper
• Breathing new insights into the role of mutant p53 in lung cancer

  2024cites this paper
• Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia

  2024cites this paper
• An updated overview of K-RAS G12C inhibitors in advanced stage non-small cell lung cancer.

  2024cites this paper
• High mitochondrial DNA levels accelerate lung adenocarcinoma progression

  2024cites this paper
• Impact of a High‐Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C Inhibitor

  2024cites this paper
• Exploring Heterogeneity: A Dive into Pre-Clinical Models of Cancer Cachexia.

  2024cites this paper
• In vitro functional assays to assess the reciprocal interplay between tumor cells and macrophages

  2024cites this paper
• Cancer research is not correlated with driver gene mutation burdens.

  2024cites this paper
• SOX17 enables immune evasion of early colorectal adenomas and cancers

  2024cites this paper
• PTEN Deficiency Induces an Extrahepatic Cholangitis-Cholangiocarcinoma Continuum via Aurora kinase A in Mice.

  2024cites this paper
• Transgenic mice applications in the study of endometriosis pathogenesis

  2024cites this paper
• Simulated galactic cosmic radiation-induced cancer progression in mice

  2024cites this paper
• Efficacy and toxicity of KRASG12C inhibitors in advanced solid tumors: a meta-analysis

  2024cites this paper
• Genomic Deletion of PFKFB3 Decreases In Vivo Tumorigenesis

  2024cites this paper
• Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

  2024cites this paper
• Beyond genetics: driving cancer with the tumour microenvironment behind the wheel

  2024cites this paper
• Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer

  2024cites this paper
• Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance

  2024cites this paper
• Oncoprotein SET-associated transcription factor ZBTB11 triggers lung cancer metastasis

  2024cites this paper
• The Abundance of KRAS and RAS Gene Mutations in Cancer.

  2024cites this paper
• Spontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice

  2024cites this paper
• An easy-to-perform protocol for culturing primary murine lung tumor cells as organoids.

  2024cites this paper
• Emerging In Vitro and In Vivo Models: Hope for the Better Understanding of Cancer Progression and Treatment

  2024cites this paper
• Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial.

  2024cites this paper
• Targeting Hyperactive Ras Signaling in Pediatric Cancer.

  2024cites this paper
• A developmental constraint model of cancer cell states and tumor heterogeneity.

  2024cites this paper
• 3’UTR-directed, kinase proximal mRNA decay inhibits C/EBPβ phosphorylation/activation to suppress senescence in tumor cells

  2024influential citation
• Early-Life Exposure to Lipopolysaccharide Induces Persistent Changes in Gene Expression Profiles in the Liver and Spleen of Female FVB/N Mice

  2023cites this paper
• Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)

  2023cites this paper
• p53 governs an AT1 differentiation programme in lung cancer suppression

  2023cites this paper
• Immunosurveillance shapes the emergence of neo-epitope landscapes of sarcomas, revealing prime targets for immunotherapy

  2023cites this paper
• A novel onco-cardiological mouse model of lung cancer-induced cardiac dysfunction and its application in identifying potential roles of tRNA-derived small RNAs.

  2023cites this paper
• How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research.

  2023cites this paper
• Experimental mouse models for translational human cancer research

  2023cites this paper
• The HDAC2-SP1 axis orchestrates pro-tumor macrophage polarization.

  2023cites this paper
• Identification of novel peptide inhibitors for oncogenic KRAS G12D as therapeutic options using mutagenesis-based remodeling and MD simulations

  2023cites this paper
• Senescent alveolar macrophages promote early-stage lung tumorigenesis.

  2023cites this paper
• Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer

  2023cites this paper
• Role of RUNX3 in Restriction Point Regulation

  2023cites this paper
• ATOH8 binds SMAD3 to induce cellular senescence and prevent Ras-driven malignant transformation

  2023cites this paper
• Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner

  2023cites this paper
• Role of spasmolytic polypeptide-expressing metaplasia in gastric mucosal diseases.

  2023cites this paper
• Runx3 Restoration Regresses K-Ras-Activated Mouse Lung Cancers and Inhibits Recurrence

  2023cites this paper
• Harnessing G-quadruplex ligands for lung cancer treatment: A comprehensive overview.

  2023cites this paper
• Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse.

  2023cites this paper
• Applying deep learning to segmentation of murine lung tumors in pre-clinical micro-computed tomography

  2023cites this paper
• Acid-base homeostasis orchestrated by NHE1 defines the pancreatic stellate cell phenotype in pancreatic cancer

  2023cites this paper
• Immune Dysfunction from Radiation Exposure

  2023cites this paper
• Small molecular inhibitors for KRAS-mutant cancers

  2023cites this paper
• Oncogenic K-Ras suppresses global miRNA function.

  2023cites this paper
• Phosphorylated nuclear DICER1 promotes open chromatin state and lineage plasticity of AT2 tumor cells in lung adenocarcinomas

  2023influential citation
• Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma

  2023influential citation
• Forward genetic screening in engineered colorectal cancer organoids identifies novel regulators of metastasis

  2023cites this paper
• Aberrant Crypt Foci - Endpoint in Colorectal Cancer

  2023cites this paper
• BAP1 Downregulates NRF2 Target Genes and Exerts Anti-Tumorigenic Effects by Deubiquitinating KEAP1 in Lung Adenocarcinoma

  2022cites this paper
• Identification of Active Bronchioalveolar Stem Cells as the Cell-of-Origin in Lung Adenocarcinoma.

  2022cites this paper
• The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner

  2022cites this paper
• Integrative single cell and spatial transcriptomics of colorectal cancer reveals multicellular functional units that support tumor progression

  2022cites this paper
• Interplay between K-RAS and miRNAs.

  2022cites this paper
• Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly

  2022cites this paper
• ERK-dependent DICER1 phosphorylation promotes open chromatin state and lineage plasticity to mediate tumor progression

  2022cites this paper
• Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system

  2022cites this paper
• Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47

  2022cites this paper
• Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors

  2022cites this paper
• Exogenous detection of 13C-glucose metabolism in tumor and diet-induced obesity models

  2022cites this paper